[Form 3] STAAR SURGICAL CO Initial Statement of Beneficial Ownership

Rhea-AI Filing Summary

STAAR Surgical director Richard T. LeBuhn filed an initial statement of beneficial ownership of securities. He reports beneficial ownership of 21,268 shares of common stock held directly. He also reports 18 shares held in three separate accounts for his daughters, over which he has voting and dispositive control. In addition, 844 shares are held by an irrevocable trust for his daughter; he is not the trustee, has no voting or dispositive power over those securities, and disclaims beneficial ownership except to the extent of his pecuniary interest. The filing notes that Mr. LeBuhn was appointed to the company’s Board of Directors on January 14, 2026.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

LeBuhn Richard T.

(Last) (First) (Middle)

C/O BROADWOOD CAPITAL, INC.

156 WEST 56TH STREET, 3RD FLOOR

(Street)

NEW YORK NY 10019

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/14/2026

3. Issuer Name and Ticker or Trading Symbol
STAAR SURGICAL CO [ STAA ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	21,268	D
Common Stock	18	I	See Footnote(1)
Common Stock	844	I	See Footnote(2)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents securities held in three separate accounts for the Reporting Person's daughters, as to which the Reporting Person has voting and dispositive control.

2. Represents securities held by an irrevocable trust for the Reporting Person's daughter, as to which the Reporting Person is not the trustee and has no voting or dispositive power over the securities. The Reporting Person disclaims beneficial ownership of the securities held directly by the trust except to the extent of his pecuniary interest therein and this report shall not be deemed an admission that the Reporting Person is a beneficial owner of such securities for purposes of Section 16 or any other purpose.

Remarks:

Mr. LeBuhn was appointed to the Board of Directors on January 14, 2026.

	Richard T. LeBuhn, /s/ Richard T. LeBuhn	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Richard T. LeBuhn’s Form 3 for STAAR Surgical (STAA) report?

The Form 3 reports Richard T. LeBuhn’s initial beneficial ownership in STAAR Surgical common stock, including direct holdings, family accounts, and a trust interest following his appointment as a director.

How many STAAR Surgical (STAA) shares does Richard T. LeBuhn hold directly?

He reports direct beneficial ownership of 21,268 shares of STAAR Surgical common stock.

What indirect STAAR Surgical (STAA) holdings are reported for Richard T. LeBuhn’s family?

He reports 18 shares held in three separate accounts for his daughters, over which he has voting and dispositive control, and 844 shares held by an irrevocable trust for his daughter.

Does Richard T. LeBuhn have voting or dispositive power over the trust’s STAAR Surgical shares?

No. The filing states he is not the trustee and has no voting or dispositive power over the 844 shares held by the irrevocable trust for his daughter.

Does Richard T. LeBuhn disclaim beneficial ownership of any STAAR Surgical (STAA) shares?

Yes. He disclaims beneficial ownership of the shares held directly by the irrevocable trust, except to the extent of his pecuniary interest in those securities.

When did Richard T. LeBuhn become a director of STAAR Surgical?

The filing states that Mr. LeBuhn was appointed to the Board of Directors on January 14, 2026.

Are any derivative securities reported in Richard T. LeBuhn’s Form 3 for STAAR Surgical?

No derivative securities are listed; the tables show only holdings of STAAR Surgical common stock.